Bundxcell Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 4

Bundxcell General Information

Description

Developer of a biopharmaceutical pipeline designed to create first-in-class innovative drugs addressing major unmet clinical needs in degenerative and immune diseases. The company offers dual technology platforms integrating induced pluripotent stem cells and tissue-specific small molecules, enabling global healthcare markets to access breakthrough treatments that advance the frontiers of cell therapy and regenerative medicine.

Contact Information

Website
www.bundxcell.com
Formerly Known As
Beisaihongsheng (Beijing) Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 1
  • Number 400 Fangchun Road, China (China Pilot Free Trade Zone)
  • Shanghai
  • China
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 3rd Floor, Building 1
  • Number 400 Fangchun Road, China (China Pilot Free Trade Zone)
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bundxcell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A1) 06-May-2026 Completed Generating Revenue
1. Early Stage VC (Series A) 16-Jul-2025 Completed Generating Revenue
To view Bundxcell’s complete valuation and funding history, request access »

Bundxcell Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sichuan Venture Capital Venture Capital Minority
Oriental Fortune Capital Venture Capital Minority
Shanghai Healthcare Capital PE/Buyout Minority
Shanghai Tiliang Investment Management Growth/Expansion Minority
To view Bundxcell’s complete investors history, request access »

Ready to get started?

Request a free trial

Bundxcell FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process